Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Leukemia

NCT04327037 is registered in ClinicalTrials.gov with Belarusian Research Center for Pediatric Oncology, Hematology and Immunology as lead sponsor.

NCT NCT04327037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04327037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Leukemia
Lead sponsor
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Phase
Phase 1
Overall status
Completed
Start date
January 2, 2019
Completion date
June 30, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute lymphoblastic, leukemia, acute myeloid